Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Abeona Therapeutics Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 55 | +8 |
| Shares | 30.1M | 446.4K | 28.8M | −945.9K (−3.2%) |
| Value | $127.8M | $1.89M | $181.7M | +$55.8M (+44.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Abeona Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 479,562 | $3.03M | 0.00% |
| Marshall Wace, LLP | 84,174 | $532.0K | 0.00% |
| Connective Capital Management, LLC | 74,913 | $480.2K | 0.45% |
| XTX Topco Ltd | 25,301 | $159.9K | 0.01% |
| Charles Schwab Investment Management Inc | 23,850 | $150.7K | 0.00% |
| Aster Capital Management (DIFC) Ltd | 21,601 | $136.5K | 0.03% |
| Jefferies Financial Group Inc. | 18,000 | $113.8K | 0.00% |
| Bank of Montreal | 14,300 | $84.8K | 0.00% |
| Jane Street Group, LLC | 13,216 | $83.5K | 0.00% |
| Palo Alto Investors LP | 12,865 | $81.3K | 0.01% |
| Game Plan Financial Advisors, LLC | 2,350 | $14.9K | 0.01% |
| Truvestments Capital LLC | 51 | $322 | 0.00% |
| Darwin Advisors, LLC | 26 | $164 | 0.00% |
| GWM Advisors LLC | 1 | $6 | 0.00% |
Sold out (6)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Virtu Financial LLC | 34,615 | $147.0K |
| Oxford Asset Management LLP | 19,059 | $80.8K |
| Creative Planning | 10,043 | $42.6K |
| Group One Trading, L.P. | 6,283 | $26.6K |
| UBS Group AG | 3,000 | $12.7K |
| Royal Bank of Canada | 214 | $1.00K |
Not filed for Q3 2024 yet (1)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 446,439 | $1.89M |